ESC Premium Access

Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction

Congress Presentation

About the speaker

Doctor Clotilde Roy

Jolimont Lobbes Hospital, La Louviere (Belgium)
1 presentation
0 follower

9 more presentations in this session

Prognostic impacts of soluble form of basigin in patients with chronic heart failure -from a prospective large clinical trial with 1,147 patients-

Speaker: Associate Professor K. Satoh (Sendai, JP)

Thumbnail

Mid regional atrial natriuretic peptide is an independent predictor of peak pulmonary capillary wedge pressure in patients with heart failure with preserved ejection fraction

Speaker: Doctor S. Nanayakkara (Melbourne, AU)

Thumbnail

Association of NGAL and AHEAD score for two-year prognosis in chronic heart failure patients (FAR NHL registry)

Speaker: Doctor K. Labr (Brno, CZ)

Thumbnail

Machine learning facilitates selecting a group of metabolites non-inferior to BNP for the diagnosis of chronic heart failure

Speaker: Doctor M. Marcinkiewicz-Siemion (Bialystok, PL)

Thumbnail

Optimizing patient selection in heart failure trials: the role of NT-proBNP

Speaker: Doctor G. Savarese (Stockholm, SE)

Thumbnail

Access the full session

Exploring biomarkers in heart failure

Speakers: Doctor C. Roy, Associate Professor K. Satoh, Doctor S. Nanayakkara, Doctor K. Labr, Doctor M. Marcinkiewicz-Siemion...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations